Markets

Curaleaf lost about $370 million over the course of 2022, just before facing a series of regulatory setbacks in subsequent...

Cresco Labs’ $2 billion acquisition of Columbia Care has been pushed back to this summer, but that should not be...

Curaleaf is betting its survival on the nascent East Coast markets, but could new investigations in at least three northeastern...